𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Conceptual, methodological, and clinical issues in the assessment of anxiety disorders

✍ Scribed by Samuel M. Turner; Larry Michelson


Publisher
Springer US
Year
1984
Tongue
English
Weight
928 KB
Volume
6
Category
Article
ISSN
1573-3505

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Conceptual and Methodological Issues in
✍ P.H. Kevin Chang; Stijn Claessens; Robert E. Cumby πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 3 views

This paper discusses alternative methodologies for measuring capital flight. While methodologies differ in approach, the identities used in balance-of-payments data make them close in the final measurement. The paper also presents capital flight estimates using the various methodologies. For a sampl

Assessing treatability in mentally disor
✍ Dr. Kirk Heilbrun; William S. Bennett; James H. Evans Jr.; Richard A. Offutt; Ha πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 494 KB πŸ‘ 1 views

The assessment of treatability in mentally disordered offenders has rarely been addressed through empirical research, despite its frequent use in clinical and legal decision-making. We describe four necessary steps for establishing the requisite research base for treatability evaluations: (a) criter

Avoidable burden of disease: conceptual
✍ Jürgen Rehm; Benjamin Taylor; Jayadeep Patra; Gerhard Gmel πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 214 KB

Determining the proportion of avoidable disease burden attributable to substance use is important for both policy development and intervention implementation. Current epidemiological theory has in principle provided a method to estimate avoidable burden of disease and the available statistical tools

Meta-analyses of the incidence and preva
✍ Sukanta Saha; David Chant; John Mcgrath πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 354 KB

## Abstract While meta‐analytic techniques are routine in the synthesis of data from randomized controlled trials, there are no clear guidelines on how best to summarize frequency data such as incidence and prevalence estimates. Based on data from two recent systematic reviews of the incidence and